ArticleBMC oral health2025
Postoperative delirium in patients with free flap reconstruction after head and neck tumor surgery: influencing factors for severity and onset time, and a prediction model.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundPostoperative delirium (POD) is common after head and neck tumor surgery with free flaps, compromising immobilization and flap survival. However, robust tools for early POD severity prediction and systematic studies on onset-time heterogeneity are lacking.
methodsIn a retrospective cohort of 65 POD patients, demographic, perioperative, and postoperative data were analyzed. POD was subclassified by severity (CAM-ICU-7 score) and onset time (24-hour threshold). Descriptive, univariate and multivariate analyses identified independent influencing factors, and a prediction model for POD severity was developed and evaluated.
resultsSeverity: 39 severe and 26 non-severe, differing in mental state, clinical manifestations, onset time, duration, and olanzapine dose. Preoperative platelet-to-lymphocyte ratio (PLR) and intraoperative tropisetron dosage were independent influencing factors. The nomogram showed strong discrimination (AUC = 0.830), good calibration and clinical benefit. Onset time: 33 acute and 32 delayed, differing in POD duration and olanzapine dose. Preoperative diastolic blood pressure and PLR were independent influencing factors.
conclusionsPOD after head and neck tumor surgery shows marked heterogeneity in severity and onset. Neutrophils and platelets may respectively drive neuroinflammation occurrence and progression, synergizing with blood pressure to regulate POD subtyping. Identified factors enable early multidimensional warning. The prediction model performs well with optimal threshold 0.45-0.55.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.